Myovant Sciences Earnings Estimate

MYOV -  USA Stock  

USD 20.88  0.06  0.29%

Many public companies, such as Myovant Sciences, manage the perception of their earnings on regular basis to make sure that analyst estimates are accurate. Future earnings calculations are essential input when attempting to value a firm.
Myovant Sciences is projected to generate -1.9333 in earnings per share on 31st of December 2022. Myovant Sciences earnings estimates module stress-tests analyst consensus about projected Myovant Sciences EPS (Earning Per Share) to derive its highest and lowest estimates based on its historical volatility. Additionally, see Stocks Correlation.

Search Earnings Estimates 

 
Refresh
Gross Profit is likely to drop to about 52.8 M in 2021. Profit Margin is likely to drop to -4.17 in 2021

Myovant Sciences Earnings Estimation Breakdown

Calculation of earning per share of Myovant Sciences is based on official Zacks consensus of 2 analysts regarding Myovant Sciences future annual earnings. Given the historical accuracy of 94.86%, the future earnings per share of Myovant Sciences is estimated to be -1.9333 with the lowest and highest values of -2.46 and -1.34, respectively. Please note that this consensus of annual earnings estimates for Myovant Sciences is an estimate of EPS before non-recurring items and including employee stock options expenses
Current EPS
-2.83
26th of July 2021
-2.46
Lowest
Estimated EPS
-1.9333
-1.34
Highest

Myovant Sciences Earnings Projection Consensus

Suppose the current estimates of Myovant Sciences' value are higher than the current market price of the Myovant Sciences stock. In this case, investors may conclude that Myovant Sciences is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Myovant Sciences' stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyCurrent EPSEPS Estimate for 31st of December 2022

2

94.86%

-2.83

-1.9333

Myovant Sciences Earnings per Share Projection vs Actual

Actual Earning per Share of Myovant Sciences refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Myovant Sciences predict the company's earnings will be in the future. The higher the earnings per share of Myovant Sciences, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

Myovant Sciences Estimated Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as Myovant Sciences, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Myovant Sciences should always be considered in relation to other companies to make a more educated investment decision.

Myovant Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact Myovant Sciences' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2021-05-11
2021-03-31-1.0206-0.890.130612 
2021-02-11
2020-12-31-0.8752-0.820.0552
2020-11-12
2020-09-30-0.759-0.750.009
2020-08-11
2020-06-30-0.6-0.370.2338 
2020-05-18
2020-03-31-0.7101-0.73-0.0199
2020-02-10
2019-12-31-0.7771-0.9084-0.131316 
2019-11-12
2019-09-30-0.7388-0.79-0.0512
2019-08-06
2019-06-30-0.9853-0.890.0953
2019-05-24
2019-03-31-1.0299-1.07-0.0401
2019-02-07
2018-12-31-0.9748-1.04-0.0652
2018-11-08
2018-09-30-0.9684-0.99-0.0216
2018-08-07
2018-06-30-0.805-0.98-0.17521 
2018-06-07
2018-03-31-0.7784-0.81-0.0316
2018-02-13
2017-12-31-0.4767-0.7-0.223346 
2017-11-13
2017-09-30-0.3833-0.5-0.116730 
2017-08-10
2017-06-30-0.29-0.39-0.134 
2017-06-14
2017-03-31-0.18-0.36-0.18100 
2017-02-13
2016-12-31-0.2567-0.150.106741 
2016-12-09
2016-09-30-0.3467-0.82-0.4733136 

About Myovant Sciences Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Myovant Sciences earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Myovant Sciences estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Myovant Sciences fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for 2021
Accumulated Retained Earnings Deficit-1 B-1.1 B
Earning Before Interest and Taxes EBIT-244.4 M-263.7 M
Earnings per Basic Share(2.83) (3.05) 
Earnings per Diluted Share(2.83) (3.05) 
Price to Earnings Ratio(7.27) (7.85) 
Earnings Before Interest Taxes and Depreciation Amortization EBITDA-241.9 M-261 M
Earnings before Tax-254.8 M-274.9 M
Myovant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for womens health and endocrine diseases. Myovant Sciences Ltd. operates as a subsidiary of Sumitovant Biopharma Ltd. Myovant Sciences operates under Biotechnology classification in the United States and is traded on New York Stock Exchange. It employs 407 people.

Myovant Sciences Investors Sentiment

The influence of Myovant Sciences' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Myovant. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.

Current Sentiment - MYOV

Myovant Sciences Investor Sentiment

Most of Macroaxis users are now bullish on Myovant Sciences. What is your trading attitude regarding investing in Myovant Sciences? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Myovant Sciences using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Additionally, see Stocks Correlation. Note that the Myovant Sciences information on this page should be used as a complementary analysis to other Myovant Sciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Complementary Tools for Myovant Stock analysis

When running Myovant Sciences price analysis, check to measure Myovant Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Myovant Sciences is operating at the current time. Most of Myovant Sciences' value examination focuses on studying past and present price action to predict the probability of Myovant Sciences' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Myovant Sciences' price. Additionally, you may evaluate how the addition of Myovant Sciences to your portfolios can decrease your overall portfolio volatility.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Equity Search
Search for activelly traded equities including funds and ETFs from over 30 global markets
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
The market value of Myovant Sciences is measured differently than its book value, which is the value of Myovant that is recorded on the company's balance sheet. Investors also form their own opinion of Myovant Sciences' value that differs from its market value or its book value, called intrinsic value, which is Myovant Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Myovant Sciences' market value can be influenced by many factors that don't directly affect Myovant Sciences underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Myovant Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine Myovant Sciences value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Myovant Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.